Skip to main content
CRS 2024 Annual Meeting and Exposition Main banner
Final Program


CRS Abstract Guide
Back

Félix Sauvage, PharmD, PhD (he/him/his)

Associate professor
Ghent University
Ghent, Belgium

Félix Sauvage was born in Dieppe (France) in 1987. He received his pharmacy degree (Pharm.D) in 2013 at University of Rouen-Normandie, France. The same year, he obtained his Master’s degree in Pharmaceutical Technology and Biopharmaceutics at University Paris-Saclay and a fellowship from the French Ministry of Higher Education and Research. He joined the Institut-Galien Paris-Saclay (University Paris-Saclay, France) for a PhD to work on the formulation of liposomes for enhancing the delivery of heat shock protein inhibitors to tumours. In 2017, Félix joined the Laboratory of General Biochemistry and Physical Pharmacy headed by Prof. Stefaan De Smedt at Ghent University as a postdoctoral research scientist. Since 2017, the use of pulsed-lasers in combination with light absorbing nanoparticles for the treatment of corneal and vitreous diseases is his major focus. In 2022, Félix was appointed assistant professor in pharmaceutical technology at Lille University, France. The same year, he obtained an ERC starting grant to investigate the combination of light and dyes for drug delivery and laser-based surgery. In 2023, Félix returned to Ghent University as associate professor at the faculty of pharmaceutical sciences where he is team leader within the Ocular Delivery Group led by Prof. Remaut.

Disclosure information not submitted.

Presentation(s):